Chapters Health System today announces its affiliation with Hope Healthcare, which adds five Florida counties to the organization's footprint. Chapters Health is one of the nation's premier not-for-profit, community-based healthcare organizations headquartered in Temple Terrace. Hope Healthcare is a not-for-profit organization recognized as a leader in providing comprehensive, coordinated care in southwest Florida. With a staff of 3,330 and more than 2,430 volunteers, Chapters Health and its affiliates combine to make it the largest, not-for-profit hospice organization in the country.
TAMPA, Fla., Dec. 14, 2022 /PRNewswire-PRWeb/ — Chapters Health System today announces its affiliation with Hope Healthcare. Chapters Health is one of the nation's premier not-for-profit, community-based healthcare organizations headquartered in Temple Terrace. Hope Healthcare is a not-for-profit organization recognized as a leader in providing comprehensive, coordinated care in southwest Florida. With a staff of 3,330 and more than 2,430 volunteers, Chapters Health and its affiliates combine to make it the largest, not-for-profit hospice organization in the country.
"This latest affiliation is further evidence of the strength of Chapters Health's unrivaled model representing an elevation in not-for-profit, chronic illness care," said Andrew Molosky, MBA, FACHE, CHPCA, president and chief executive officer for Chapters Health. "The ability to gain economy of scale, intellectual capital and best practice while preserving brand legacy, board governance and executive presence is the future."
This affiliation is yet another opportunity for Chapters Health to preserve, as well as enhance, the not-for-profit end-of-life model of comprehensive, community-based care. With combined resources of all Chapters Health affiliates, healthcare services will be provided to residents in 35 Florida counties and four Georgia counties, allowing more than 72,400 lives to be touched annually.
"By becoming an affiliate member of the Chapters Health family, we can preserve our legacy and further our vital mission to provide comforting care throughout Charlotte, Collier, Glades, Hendry and Lee counties," said Samira K. Beckwith, president and chief executive officer for Hope Healthcare.
"At Chapters Health, we are on a journey to incorporate community health services, social determinants of health and primary care into our value-based designs and now we have a new travel partner with us," said Molosky. "Using our matrixed approach of integrating home health, advanced illness management, telemedicine, social determinants of health and primary care, we are moving chronic illness care further upstream to deliver the low-cost, high-quality experience that for so long has been the provenance of hospice to its patients, families and communities.
"For Chapters Health, the most exciting part about this second affiliation in 2022 is it represents another step in elevating home and community-based, end-of-life care. If your organization wants to learn more about securing its future, we stand ready to assist. Let's talk about what could be," added Molosky.
About Chapters Health System
As a progressive leader and premier health system, Chapters Health System is dedicated to delivering innovative home health, palliative and hospice care along with durable medical equipment and pharmacy services. Since 1983 as a community-based, not-for-profit organization, Chapters Health has provided choices, education and guidance through its managed affiliates. All offerings are provided in order to improve the patient/family experience well in advance of end-of-life needs. In 2022, Chapters Health earned certified status for information security from HITRUST; for the fifth consecutive year was recognized as a great workplace in the Aging Services category by the independent analysts at the Great Place to Work® Institute; and in 2021 was named a Top Workplace by the Tampa Bay Times. To learn more, visit http://www.chaptershealth.o rg, like us on Facebook or follow us on Twitter and LinkedIn.
About Hope Healthcare
Hope Healthcare is a safety net organization providing care for southwest Florida residents who are frail and aging or living with serious illnesses. The community-based, not-for-profit organization serves five Florida counties and offers support 24 hours a day, seven days a week. For more information, visit HopeHCS.org.
Media Contact
Phoebe Ochman, Chapters Health System, 813-532-7221, ochmanp@chaptershealth.org
Amy Objartel, Hope Healthcare, 239-985-7726, Amy.Objartel@hopehcs.org
Twitter, Facebook
SOURCE Chapters Health System
Hours after Alex Ovechkin became the first NHL player to score 800 goals with one team, Avidity Biosciences announced an industry first of its own. The precommercial drug developer delivered positive results in a phase 1 clinical trial evaluating AOC-1001 in myotonic dystrophy type 1 (DM1). The drug candidate utilizes RNA interference (RNAi) to treat the rare muscular disease at the genetic level.
A "bruising" FDA meeting for Cytokinetics was actually a blessing in disguise, an analyst said Wednesday as CYTK stock surged.
Kymera unveiled promising results for its skin-disease treatment on Wednesday, snagging interest from Sanofi and sending KYMR stock flying.
Avidity unveiled "compelling" results from a muscular dystrophy study Wednesday, leading RNA stock to skyrocket to a three-month high.
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Moderna could have a winner with its personalized cancer vaccine. But the company also faces big questions.
Chardan Capital Markets analyst Geulah Livshits now rates the biotech company at Neutral, down from Buy.
Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces data, including new evidence, from an interim analysis of its open-label extension study evaluating the investigational drug leniolisib, an oral, selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor, to treat adult and adolescent patients with activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency. Principal investigator V. Koneti Rao, M.D., a staff ph
Vanda Pharmaceuticals Inc. faces a potential revenue hit after a Delaware court said two rival drugmakers would not be violating its patent if they were to bring a generic form of its sleep disorder drug, Hetlioz, to market. The ruling from the U.S. District Court for Delaware late Tuesday sets the stage for New Jersey’s Teva Pharmaceuticals USA Inc. and Canada’s Apotex Inc. to begin marketing and selling Hetlioz’s generic counterpart using the active ingredient tasimelteon.
Yahoo Finance health correspondent Anjalee Khemlani joins the Live show to review Moderna and Merck shares following positive results seen in their joint cancer vaccine trial.
Cambridge venture firm Flagship Pioneering is spinning out a new startup, and it has a veritable powerhouse as its CEO: Margo Georgiadis, former president of the Americas at Google and erstwhile CEO of Ancestry.com and Mattel Inc.
Florida Gov. Ron DeSantis on Tuesday defended his launch of the Public Health Integrity Committee – a state alternative to the Centers for Disease Control and Prevention – and in the process waded into vaccine-skeptic territory on friendly Fox News airwaves.Laura Ingraham introduced DeSantis as someone who “has fought relentlessly against the medical cartel’s silencing campaign,” and referenced how the governor earlier in the day also called for a statewide grand jury investigation into what he
Lucy Harman, 20, was in her first year of university in September 2020 when she noticed she was rapidly losing weight
The research published in the Journal of the American College of Cardiology also highlighted a key nutrient to avoid.
U.S. life sciences company Illumina Inc on Tuesday defended its $7.1 billion acquisition of biotech firm Grail Inc , pledging to keep selling its DNA sequencing services to other firms, as it seeks to head off a potential vote by U.S. antitrust regulators to kill the deal. The Federal Trade Commission, which enforces antitrust law, filed a complaint in March 2021 to stop Illumina's bid for its former subsidiary Grail. The agency cited concerns that Illumina, the dominant provider of DNA sequencing for multi-cancer early detection tests, might raise prices or refuse to keep selling to rivals of Grail, which is seeking to market a powerful test to diagnose many kinds of cancer from a single blood test.
Eli Lilly said Tuesday it plans to advance its next-generation obesity treatment into final-phase testing, but LLY stock dipped on guidance.
Cellectis S.A (NASDAQ: CLLS) highlighted updated clinical data on its Phase 1/2a BALLI-01 trial (evaluating UCART22) and on its Phase 1 AMELI-01 trial (evaluating UCART123). Compared to the last clinical update on BALLI-01 at ASH 2021, the presented data comes from five additional patients who received UCART22 at dose level 3 (DL3) 5×106 cells/kg after lymphodepletion with FCA. Evidence of UCART22 anti-tumor activity was observed in 60% (n=3) of the five patients. A patient experienced a durable
Two examples are Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). Pfizer has been one of the most successful companies in the coronavirus vaccine market with Comirnaty. Pfizer has beefed up its pipeline recently, partly thanks to acquisitions.
The U.S. government announced a new purchase agreement for Pfizer Inc's (NYSE: PFE) COVID-19 antiviral treatment Paxlovid. This purchase supplements the 20 million treatment courses previously contracted by and already delivered to the U.S. Government. The additional 3.7 million treatment courses are planned for delivery by early 2023. Related: Pfizer Expects $10-$15B From mRNA Vaccine Sales By 2030, Sees $17B Revenues Lost Due To Patent Expiry. The Biden administration previously agreed to pay
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal year ended September 30, 2022. All references to "$" in this release refer to United States dollars, unless otherwise indicated.
